Using a murine model of UUO, Grgic et al. demonstrated a therapeutic usefulness of targeting the intermediate-conductance Ca2+-activated K+-channels (Kca3.1) in the treatment of renal fibrosis, since these channels were overexpressed in proliferating fibroblasts [45]. The gene discussed is KCNN4; the disease is renal fibrosis.